MeitY Startup Hub onboards MergerDomo to strengthen start-up ecosystem in India
Posted By - Investment Banker
A leading molecular diagnostic service business strategically headquartered in New Delhi is looking to sell out. The business also provides pathological services and various testing facilities including tests for infectious diseases, cancer, metabolic diagnostic, prenatal diagnostic, genetic disorder etc. The facility does more than 7500 tests every month. Also, the facility equipments are USFDA and CE approved. Providing its services in various locations like Delhi, Faridabad, Gurgaon, Uttar Pradesh and Rajasthan
 Deal Size
|
INR 15 - 20 Cr |
| Motives For Sellout | Strategic Realignment |
Industry Pharmaceuticals |
Sub-Industry Diagnostic Imaging Centres |
| Management is open to continue with the business for handholding the new investor/buyers | |
| 2017 (in Cr) | 2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | ||
|---|---|---|---|---|---|
| Sales | N.D | N.D | INR 3 Cr | INR 4.8 Cr | |
| EBITDA | |||||
| PAT | |||||
| TOTAL DEBT | N.D | N.D | N.D | N.D | |
Business Model
If you are interested in connecting with business, please send an Expression of Interest and receive Information Memo to take this opportunity further
EXPRESS INTEREST MARK FAVOURITE
